Ireland
--:--IST
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Siegen
Clinical trial register · Germany

Clinical Trials in Siegen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5042 matching records held by the registry are in this view. Synced 02 Oct 2026, 03:17 UTC
5042
Studies in scope
all four open statuses
2868
Recruiting now
open to new participants
984
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 888 Essen 763 Dresden 709 Heidelberg 626
Narrow the registerReset
Recruitment status
Phase
Site location
Berlin1586 Hamburg888 Essen763 Dresden709 Heidelberg626
All 637 locations
Target enrolment
to

Trials with a site in Siegen

10 of 5042 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
NCT07412756Depressive Disorder, Major
Eli Lilly and Company
Phase 3
1,000
Aachen, Berlin, Bielefeld, Chemnitz, Mainz, Mannheim, Schwerin, Siegen
2026-02-09
Recruiting
SL-START - SubLingual Apomorphine Schemes of TitrAtion in Real-world Treatment
NCT07145190Parkinson Disease
Bial - Portela C S.A.
Observational
90
Berlin, Bochum, Freiburg im Breisgau, Fulda, Hetzdorf, Osnabrück, Siegen, Sundern
2025-08-27
Recruiting
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
NCT06782490Multiple Sclerosis Spasticity
Celgene
Phase 2
200
Würzburg, Kassel, Bochum, Münster, Siegen, Meisenheim, Jena, Bielefeld
2025-06-05
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
NCT06742996Mantle Cell Lymphoma, B Cell Lymphoma
BeOne Medicines
Phase 3
300
Chemnitz, Frankfurt am Main, Halle, Hamburg, Mutlangen, München, Siegen
2025-03-05
Active, closed
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
NCT06806293Menstrual Migraine (MM)
AbbVie
Phase 3
468
Erbach im Odenwald, Westerstede, Greifswald, Bielefeld, Ibbenbueren, Siegen, Chemnitz, Leipzig
2025-02-10
Active, closed
Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
NCT06543914Migraine
AbbVie
Observational
1,314
Heidelberg, Tübingen, Hoppegarten, Bad Homburg, Oldenburg, Greifswald, Siegen, Velbert
2024-11-26
Recruiting
Non Interventional German Leptomeningeal Disease Register
NCT06146010Meningeal Neoplasms, Leptomeningeal Disease
University Hospital Tuebingen
Observational
50
Bonn, Mannheim, München, Münster, Siegen, Tübingen, Ulm
2024-06-26
Active, closed
Safety and Performance of the Biphasic Plate Distal Femur: A Multicenter Case Series
NCT06028971Distal Femur Fracture, Periprosthetic Fractures, Intra-Articular Fractures, Supracondylar Fracture
41medical AG
Observational
60
Münster, Siegen
2024-02-29
Recruiting
Total en Bloc Urethra Preservation at Robot-assisted Prostatectomy IDEAL Stage 2a
NCT07678489Prostate Cancer (Localized), Urinary Incontinence (C61)
Sami-Ramzi Leyh-Bannurah
Not applicable
60
Düsseldorf, Siegen
2024-01-30
Recruiting
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
NCT04728893Hematologic Malignancies, Waldenstroms Macroglobulinaemia, Non-Hodgkins Lymphoma, Chronic Lymphocytic Leukaemia
Merck Sharp & Dohme LLC
Phase 2
490
Ulm, Cologne, Siegen, Dresden
2021-04-05
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 2 October 2026. https://priyalifescience.com/clinical-trials-germany/city/siegen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,042 studies in total at the last sync on 02 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Siegen.

How many clinical trials are recruiting in Siegen?

7 of the 10 studies on this page are recruiting new participants as of the 02 Oct 2026, 03:17 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Siegen), 10 studies
PhaseStudiesRecruitingShare
Observational4240%
Phase 33230%
Phase 22220%
Not applicable1110%

Most active sponsors

Lead sponsors with the most studies (Siegen)
Lead sponsorStudiesRecruiting
AbbVie20
41medical AG10
BeOne Medicines11
Bial - Portela C S.A.11
Celgene11
Eli Lilly and Company11
Merck Sharp & Dohme LLC11
Sami-Ramzi Leyh-Bannurah11
University Hospital Tuebingen11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.